Literature DB >> 27102004

Unusual association of amyotrophic lateral sclerosis and myasthenia gravis: A dysregulation of the adaptive immune system?

Maria Del Mar Amador1, Nadia Vandenberghe2, Nawel Berhoune2, Jean-Philippe Camdessanché3, Sophie Gronier4, Emilien Delmont4, Claude Desnuelle4, Pascal Cintas5, Sophie Pittion6, Sarah Louis7, Sophie Demeret8, Timothée Lenglet1, Vincent Meininger1, François Salachas1, Pierre-François Pradat9, Gaëlle Bruneteau10.   

Abstract

Myasthenia gravis is an autoimmune disorder affecting neuromuscular junctions that has been associated with a small increased risk of amyotrophic lateral sclerosis (ALS). Here, we describe a retrospective series of seven cases with a concomitant diagnosis of ALS and myasthenia gravis, collected among the 18 French reference centers for ALS in a twelve year period. After careful review, only six patients strictly met the diagnostic criteria for both ALS and myasthenia gravis. In these patients, limb onset of ALS was reported in five (83%) cases. Localization of myasthenia gravis initial symptoms was ocular in three (50%) cases, generalized in two (33%) and bulbar in one (17%). Median delay between onset of the two conditions was 19 months (6-319 months). Anti-acetylcholine receptor antibodies testing was positive in all cases. All patients were treated with riluzole and one had an associated immune-mediated disease. In the one last ALS case, the final diagnosis was false-positivity for anti-acetylcholine receptor antibodies. The co-occurrence of ALS and myasthenia gravis is rare and requires strict diagnostic criteria. Its demonstration needs thoughtful interpretation of electrophysiological results and exclusion of false positivity for myasthenia gravis antibody testing in some ALS cases. This association may be triggered by a dysfunction of adaptive immunity.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Immunology; Myasthenia gravis; Neuromuscular transmission

Mesh:

Substances:

Year:  2016        PMID: 27102004     DOI: 10.1016/j.nmd.2016.03.004

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  6 in total

1.  Amyotrophic lateral sclerosis and myasthenia gravis: association or chance occurrence?

Authors:  Silvia de Pasqua; Francesco Cavallieri; Roberto D'Angelo; Fabrizio Salvi; Nicola Fini; Roberto D'Alessandro; Rita Rinaldi; Antonio Fasano; Jessica Mandrioli
Journal:  Neurol Sci       Date:  2016-12-02       Impact factor: 3.307

2.  Coexistence of myasthenia gravis and amyotrophic lateral sclerosis in a Bosnian male: an unusual clinical presentation.

Authors:  Renata Hodzic; Nermina Piric; Sanela Zukic; Amela Cickusic
Journal:  Acta Myol       Date:  2021-03-31

3.  Myasthenic symptoms in anti-low-density lipoprotein receptor-related protein 4 antibody-seropositive amyotrophic lateral sclerosis: two case reports.

Authors:  Hisashi Takahashi; Yu-Ichi Noto; Naoki Makita; Yukie Kushimura-Okada; Ryotaro Ishii; Akihiro Tanaka; Tomoyuki Ohara; Shunya Nakane; Osamu Higuchi; Masanori Nakagawa; Toshiki Mizuno
Journal:  BMC Neurol       Date:  2016-11-18       Impact factor: 2.474

4.  Amyotrophic Lateral Sclerosis and Myasthenia Gravis Overlap Syndrome: A Review of Two Cases and the Associated Literature.

Authors:  Hongfei Tai; Liying Cui; Yuzhou Guan; Mingsheng Liu; Xiaoguang Li; Yan Huang; Jing Yuan; Dongchao Shen; Dawei Li; Feifei Zhai
Journal:  Front Neurol       Date:  2017-05-22       Impact factor: 4.003

5.  Late-onset Myasthenia Gravis Accompanied by Amyotrophic Lateral Sclerosis with Antibodies against the Acetylcholine Receptor and Low-density Lipoprotein Receptor-related Protein 4.

Authors:  Keiko Ohnari; Kazumasa Okada; Osamu Higuchi; Hidenori Matsuo; Hiroaki Adachi
Journal:  Intern Med       Date:  2018-10-15       Impact factor: 1.271

6.  Very Early Involvement of Innate Immunity in Peripheral Nerve Degeneration in SOD1-G93A Mice.

Authors:  Daniela Francesca Angelini; Federica De Angelis; Valentina Vacca; Eleonora Piras; Chiara Parisi; Michele Nutini; Alida Spalloni; Francesca Pagano; Patrizia Longone; Luca Battistini; Flaminia Pavone; Sara Marinelli
Journal:  Front Immunol       Date:  2020-11-20       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.